Y-27632 Dihydrochloride: Selective ROCK1/2 Inhibitor for Advanced Cytoskeletal and Cancer Research

Executive Summary: Y-27632 dihydrochloride is a highly selective small-molecule inhibitor of Rho-associated protein kinases ROCK1 and ROCK2, with an IC50 of approximately 140 nM for ROCK1 and a Ki of 300 nM for ROCK2, demonstrating >200-fold selectivity over other kinases (product page). This compound blocks Rho-mediated stress fiber formation, regulates cell cycle transitions from G1 to S phase, and inhibits cytokinesis in vitro (Li et al. 2024). Y-27632 is soluble in water, DMSO, and ethanol, with recommended storage below -20°C and use as a freshly prepared solution. In vivo studies demonstrate its capacity to suppress tumor invasion and metastasis in mouse models. It is a gold-standard tool for dissecting Rho/ROCK signaling in stem cell, cancer, and cytoskeletal research.

Biological Rationale

Rho-associated coiled-coil containing protein kinases (ROCK1 and ROCK2) are serine/threonine kinases critical for actin cytoskeleton organization, cell motility, and contractility. The Rho/ROCK pathway regulates stress fiber formation, focal adhesion, and cell migration. Dysregulation of ROCK signaling is linked to tumor progression, metastasis, and impaired stem cell viability (related article). Inhibiting ROCK kinases thus enables researchers to interrogate cytoskeletal dynamics, cell cycle events, and mechanisms of cellular invasion. Y-27632 dihydrochloride is a benchmark selective inhibitor for these applications.

Mechanism of Action of Y-27632 dihydrochloride

Y-27632 dihydrochloride competitively inhibits the ATP-binding site of the catalytic domains of ROCK1 and ROCK2. Its IC50 for ROCK1 is ~140 nM and Ki for ROCK2 is 300 nM, with more than 200-fold selectivity over kinases such as PKC, cAMP-dependent protein kinase, MLCK, and PAK (ApexBio). This inhibition blocks phosphorylation of downstream effectors such as myosin light chain (MLC), LIM kinase, and cofilin, resulting in the collapse of actin stress fibers and inhibition of cell contraction. The compound thereby impairs cell motility, adhesion, and cytokinesis, and can modulate the cell cycle and apoptosis under specific conditions (mechanistic insights). This precise targeting makes Y-27632 a preferred agent for dissecting Rho/ROCK pathway function.

Evidence & Benchmarks

• Y-27632 dihydrochloride inhibits ROCK1 with an IC50 of 140 nM and ROCK2 with a Ki of 300 nM, showing >200-fold selectivity over other kinases (ApexBio).
• It disrupts Rho-mediated actin stress fiber formation in a dose-dependent manner in mammalian cells (Li et al. 2024).
• In vitro, Y-27632 reduces proliferation of prostatic smooth muscle cells in a concentration-dependent manner (10–50 μM, 24–72 h) (ApexBio).
• In vivo, Y-27632 administration decreases tumor invasion and metastasis in mouse models of colon cancer (Li et al. 2024).
• Y-27632 enhances survival and colony formation of human pluripotent stem cells by preventing dissociation-induced apoptosis (see also).

Applications, Limits & Misconceptions

Y-27632 dihydrochloride is used for:

• Modulating cytoskeletal organization in cell migration and adhesion assays.
• Enhancing viability and expansion of stem cells, especially human pluripotent stem cells and iPSCs.
• Inhibiting tumor cell invasion and metastasis in preclinical cancer models.
• Dissecting Rho/ROCK pathway roles in cytokinesis, cell proliferation, and apoptosis.

This article updates and extends previous reviews by providing quantitative benchmarks and clarifying storage and solubility parameters. It also contrasts with recent studies on the DR5-ROCK1-PD-L1 axis by focusing on the broader cytoskeletal and stem cell research context.

Common Pitfalls or Misconceptions

• Y-27632 is not effective against kinases outside the ROCK family at standard working concentrations; it does not broadly inhibit PKC, MLCK, or PAK (>200-fold selectivity).
• Long-term storage of Y-27632 solutions (>1 month) is discouraged due to potential degradation; always prepare fresh or store at -20°C for short durations.
• Not all cell types respond similarly; some non-muscle cell types may show less pronounced cytoskeletal changes.
• Y-27632 does not directly suppress bacterial genotoxins (e.g., colibactin) and should not be used as an antimicrobial agent.

Workflow Integration & Parameters

Y-27632 dihydrochloride is supplied as a solid and should be stored desiccated at 4°C or below. For use, dissolve in DMSO (≥111.2 mg/mL), ethanol (≥17.57 mg/mL), or water (≥52.9 mg/mL). Warming to 37°C or using an ultrasonic bath can enhance solubility. Prepare working concentrations between 1–50 μM for cell culture. Stock solutions should be aliquoted and stored below -20°C and protected from repeated freeze-thaw cycles. For in vitro use, add Y-27632 directly to cell culture medium; for in vivo studies, refer to published dosing regimens (e.g., 30 mg/kg IP in mice, as per Li et al. 2024). Always verify compound integrity and avoid prolonged light exposure.

Conclusion & Outlook

Y-27632 dihydrochloride is a validated, selective ROCK1/2 inhibitor that enables detailed study of Rho/ROCK signaling, cytoskeletal regulation, stem cell viability, and tumor invasion. Its quantitative potency, robust selectivity, and well-defined preparation protocols make it an indispensable tool in both basic and translational research. For more information or to purchase, visit the Y-27632 dihydrochloride product page (A3008). Ongoing research is expanding its applications in combinatorial cancer therapies and regenerative medicine. For a mechanistic deep dive, see this advanced review, which complements the current evidence base.